Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134814) titled 'Development and Clinical Application of a Broadly Applicable Detection System for Tumor Antigen-Specific Cellular Immune Function in Patients with Hepatocellular Carcinoma Based on Immunodominant T-Cell Epitope Profiles' on Oct. 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Second Hospital of Nanjing
Condition:
Hepatocellular carcinoma (HCC)
Intervention:
Epitope Screening and Assay Development Cohort:N/A
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-02
Target Sample Size: Epitope Screening and Assay Development Cohort:300;Clinical A...